Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume OverloadMilton Packer, Faı̈ez Zannad, João Pedro Ferreira et al.|Journal of the American College of Cardiology|2021Cited by 168
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trialMilton Packer, Faı̈ez Zannad, Stefan D. Anker et al.|European Heart Journal|2020Cited by 135